A study presented at the Congress of the European Academy of Neurology 2020 found that adults with both diabetes and Parkinson's disease who took metformin performed significantly better on tests assessing motor and nonmotor function, as well as on certain measures of cognitive impairment, compared with those who did not take metformin. The findings, based on data from a cohort of 19 PD and diabetes patients, indicate "a potential protective effect of metformin in PD," researcher Daniele Urso said.
Metformin may benefit patients with Parkinson's, diabetes
Sign up for DiabetesPro SmartBrief
News for diabetes health professionals
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.